Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:46 AM
Ignite Modification Date:
2025-12-24 @ 11:46 AM
NCT ID:
NCT02377661
Eligibility Criteria:
Inclusion Criteria:
* Written informed consent
* office blood pressure ≥ 140/90 mmHg
* ACE inhibitor intolerance (experimental arm)
Exclusion Criteria:
* Malignant disease with life expectancy \< 6 months
* Women of childbearing potential (ICH definition) or breastfeeding
* Contraindications or allergies against olmesartan, amlodipine or hydrochlorothiazide (experimental arm)
* Chronic kidney disease grade IV or V (eGFR \< 30 ml/min)
* Recent myocardial infarction or stroke within the preceding 3 months
* Participation in another clinical trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT02377661
Study Brief:
Protocol Section:
NCT02377661